PHARMACY BENEFITS MANAGEMENT (PBM) PROGRAM
Maximum Daily Dosage Limit for Suboxone® and Subutex® - Effective February, 2013 (Physician)
Agents Added to Quantity Limit and Maximum Dosage Policy for Recipients in Legacy Medicaid Effective January 15, 2013
(Pharmacist)
(Prescriber)
Preferred Drug
List/Prior Authorization List
(Updated List from the October 31, 2012 Meeting - Effective January 1, 2013)
Letter to Pharmacy Providers & Prescribing Practitioners
Attention All Pharmacy Providers - PBMs Associated with BAYOU HEALTH Pre-Paid Plans
LA Medicaid Pharmacy Reimbursement Notice to Providers - October 29, 2012
Pharmacy Reimbursement Change - Effective September 5, 2012
Pharmacy Preferred Drug List (PDL) Online
Important Update on NCPDP D.0 and 5010 270/271 Transactions Implementation Effective January 1, 2012
Summary of Changes to the POS User Manual for November, 2011
Pharmacy Provider Outreach Article
Pharmacy Policy Update Letter 9/2/11
Attention Pharmacy Providers - Update on NCPDP D.0 Implementation
Flood 2011 – Pharmacy Provider Letter, May 13, 2011
Quantity Limits, Maximum Dosages and ICD-9-CM Diagnosis Code Requirement for C-II Narcotics
Quantity Limits on Triptans and Carisoprodol, and Maximum Dosage on Buprenorphine Patches - Pharmacists Effective March 30, 2011
Quantity Limits, Maximum Dosages and ICD-9-CM Diagnosis Code Requirement for C-II Narcotics
Quantity Limits on Triptans and Carisoprodol, and Maximum Dosage on Buprenorphine Patches – Prescribing Providers Effective March 30, 2011
Monthly Prescription Limit Letter – Pharmacists Effective December 1, 2010
Monthly Prescription Limit Letter – Prescribing Providers Effective December 1, 2010
Reimbursement Criteria for Palivizumab (Synagis)
Pharmacy Provider Letter: Revised Louisiana Maximum Allowable Cost (LMAC) Reimbursement Methodology 1/27/10
Pharmacy Provider Letter: Suboxone®/Subutex® Criteria for Reimbursement
Physician Letter: Suboxone®/Subutex® Criteria for Reimbursement
Monthly Prescription Limit Letter - Pharmacists Effective May 1, 2009
Monthly Prescription Limit Letter - Prescribing Providers Effective May 1, 2009
Tamper-Resistant Prescription Pads Required October 1, 2008 08/29/08 The LMMIS Pharmacy
Benefits Management (PBM) Program has responsibility for the coordination of all Medicaid
pharmacy-related services. Claim Processing of
15, 000, 000 Rx/year through Point of Sale Clinical/policy claim
editing Prospective and Retrospective Drug Utilization Review
Programs (DUR) Pharmacy Help Desk Services Recipient Disease state brochures Provider Disease state brochures Drug rebate program Post payment reviews
Other services available to pharmacy providers include: Electronic Remittance Advices Data warehouse support services Reference file maintenance The PA process is supported by the operations of the
University of Louisiana at Monroe College of Pharmacy (ULM) Prior Approval
Desk. For more information on specific components of the
Pharmacy Benefits Program, click on the “bold faced” services noted
above.
Prescribing
Provider File (PPN)
(Zip file)Listing of prescribing providers
sorted by
provider name.
Prescribing
Provider File (PPN)
(Zip file)Listing of prescribing providers
sorted by
provider type.
Pharmacy Prior Authorization
Program
Drug Appendices
Drug lists identifying program pay
status
DSM Program
Disease State Management Program
Pharmacy
Benefits Management Services, Chapter 37 - Updated January 1, 2012
Provider manual containing policies
and procedures needed to receive reimbursement for covered services
provided to eligible Louisiana Medicaid recipients.
Point
of Sale (POS) User Guide
User Manual for the Pharmacy Point
of Sale Program.
POS
Vendor Specs Document
Vendor Specifications Document for
the POS Adjudication System.
POS
Vendor Specs Appendices
Vendor Specifications Appendices
for the POS Adjudication System.
Provider/Recipient
Correspondence
Letters and updates sent to pharmacy
and prescribing providers and Medicaid recipients